Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for CorMedix (CRMD) over the last 11 years, with Q3 2025 value amounting to $33.8 million.

  • CorMedix's Change in Acquisitions & Divestments rose 32241.11% to $33.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.7 million, marking a year-over-year increase of 524.76%. This contributed to the annual value of $48.1 million for FY2024, which is 2027.14% down from last year.
  • Latest data reveals that CorMedix reported Change in Acquisitions & Divestments of $33.8 million as of Q3 2025, which was up 32241.11% from $8.1 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Change in Acquisitions & Divestments ranged from a high of $33.8 million in Q3 2025 and a low of $13.0 during Q4 2021
  • Its 5-year average for Change in Acquisitions & Divestments is $9.1 million, with a median of $8.0 million in 2022.
  • As far as peak fluctuations go, CorMedix's Change in Acquisitions & Divestments crashed by 9999.86% in 2021, and later skyrocketed by 6846143846.15% in 2022.
  • CorMedix's Change in Acquisitions & Divestments (Quarter) stood at $13.0 in 2021, then surged by 68461438.46% to $8.9 million in 2022, then grew by 20.79% to $10.8 million in 2023, then crashed by 53.49% to $5.0 million in 2024, then surged by 575.86% to $33.8 million in 2025.
  • Its last three reported values are $33.8 million in Q3 2025, $8.1 million for Q2 2025, and $9.8 million during Q1 2025.